Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial Comparing the Relative Efficacy of Deferiprone to That of Deferoxamine in Removing Excess Cardiac Iron in Thalassemia Major Patients

NCT00105495 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.

NCT NCT00105495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00105495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial Comparing the Relative Efficacy of Deferiprone to That of Deferoxamine in Removing Excess Cardiac Iron in Thalassemia Major Patients
Lead sponsor
ApoPharma
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2002
Completion date
October 31, 2004
Enrollment
60
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hemosiderosis, thalassemia major